As of April 25, 2023, the NIHB Program will expand coverage of the continuous glucose monitoring (CGM) systems Dexcom G6, Free Style Libre and Free Style Libre 2
These devices will be covered as limited use benefits for clients managing diabetes with insulin.
Prior approval is required. Coverage criteria are noted in the Drug Benefit List
NIHB Program continues to provide coverage of diabetes test strips. Clients managing diabetes with insulin can access up to 800 test strips per 100 days.
Clink HERE to view our statement.